title: Review: Angiotensin II receptor blocker plus angiotensin-converting enzyme inhibitor increases risk for adverse effects.
authors.affiliation: Duke Clinical Research Institute, Durham, North Carolina, USA.
authors.forename: Christopher B
authors.initials: CB
authors.lastname: Granger